InVivo Therapeutics

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

1 Kendall Sq Fl 4 Bldg 1400, Cambridge, ...

Revenue

$114.5 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company headquartered in Cambridge, Massachusetts, focused on developing and commercializing technologies for the treatment of spinal cord injuries. Founded in 2005 on the basis of proprietary technology co-invented by researchers at the Massachusetts Institute of Technology and Harvard Medical School, the company utilizes polymers as a platform technology to develop treatments aimed at restoring function in individuals paralyzed as a result of traumatic spinal cord injury. Its lead product candidate, the Neuro-Spinal Scaffold, is a bioresorbable and biocompatible implantable device designed to support spinal cord tissue and promote neurological recovery following acute injury. The company also maintains a preclinical development program targeting chronic spinal cord injury. InVivo Therapeutics has received recognition from the American Spinal Injury Association and has conducted multipleRead more
Popular SearchesInVivo Therapeutics CorpSIC Code 28,283NAICS Code 32,325Show more

InVivo Therapeutics Org Chart

PhoneEmail
JN
United States flag for contact location.

Head of Quality Assurance

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is InVivo Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to InVivo Therapeutics

Compare insights from companies similar to InVivo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

InVivo Therapeutics

$114.5M
51-200
Private
-
-
JN
John NagleHead of Quality Assurance
$569.6M
201-500
Public
$68.5M
2018
EC
Erin CampanyChief People Officer
$66.2M
51-200
Public
$85M
2006
Lindsay Rosenwald, President & Chief Executive Officer & Chairman at Fortress Biotech
Lindsay RosenwaldPresident & CEO & Chairman
$18.1M
501-1,000
Public
$100M
2008
Adriana Cabre, Chief Human Resources Officer at Crinetics Pharmaceuticals
Adriana CabreChief Human Resources Officer
$14.8M
51-200
Public
$60.9M
1990
$11.1M
201-500
Public
$35.1M
2005
Aj Bergmann, Chief Financial Officer at Capricor Therapeutics
Aj BergmannChief Financial Officer
$6.2M
51-200
Private
-
2012
MW
Michael WiebeMaterials Handler
Illustration of an envelope

InVivo Therapeutics Tech Stack

A closer look at the technologies used by InVivo Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding InVivo Therapeutics

What is InVivo Therapeutics's official website?
InVivo Therapeutics's official website is www.invivotherapeutics.com
What is InVivo Therapeutics's Revenue?
InVivo Therapeutics's revenue is $114.5 Million
What is InVivo Therapeutics's SIC code?
InVivo Therapeutics's SIC: 28,283
What is InVivo Therapeutics's NAICS code?
InVivo Therapeutics's NAICS: 32,325
How many employees does InVivo Therapeutics have?
InVivo Therapeutics has 51-200 employees
What industry does InVivo Therapeutics belong to?
InVivo Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What is InVivo Therapeutics competition?
InVivo Therapeutics top competitors include: Crinetics Pharmaceuticals, Asterias Biotherapeutics, Capricor Therapeutics, Mirum
What technology does InVivo Therapeutics use?
Some of the popular technologies that InVivo Therapeutics uses are: WordPress.org, reCAPTCHA, PHP, Cloudflare CDN
What does InVivo Therapeutics do?

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company headquartered in Cambridge, Massachusetts, focused on developing and commercializing technologies for the treatment of spinal cord injuries. Founded in 2005 on the basis of proprietary technology co-invented by researchers at the Massachusetts... Institute of Technology and Harvard Medical School, the company utilizes polymers as a platform technology to develop treatments aimed at restoring function in individuals paralyzed as a result of traumatic spinal cord injury. Its lead product candidate, the Neuro-Spinal Scaffold, is a bioresorbable and biocompatible implantable device designed to support spinal cord tissue and promote neurological recovery following acute injury. The company also maintains a preclinical development program targeting chronic spinal cord injury. InVivo Therapeutics has received recognition from the American Spinal Injury Association and has conducted multiple clinical trials, including its INSPIRE study program.Read More

Is InVivo Therapeutics a public company?
InVivo Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about InVivo Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.